Blockade of interleukin-17A results in reduced atherosclerosis in apolipoprotein E-deficient mice.
about
The emerging role of IL-17 in the pathogenesis of psoriasis: preclinical and clinical findingsThe role of inflammation in cardiovascular diseases: the predictive value of neutrophil-lymphocyte ratio as a marker in peripheral arterial diseasePeriodontal Disease-Induced Atherosclerosis and Oxidative StressMacrophages in vascular inflammation--From atherosclerosis to vasculitisInflammation in arterial diseasesγδ-T cells: an unpolished sword in human anti-infection immunityThe role of costimulatory receptors of the tumour necrosis factor receptor family in atherosclerosisThe influence of innate and adaptive immune responses on atherosclerosisT cells in atherosclerosisInterleukin-17 and acute coronary syndromeMetainflammation in Diabetic Coronary Artery Disease: Emerging Role of Innate and Adaptive Immune ResponsesThe Roles of CD137 Signaling in AtherosclerosisImmunity, atherosclerosis and cardiovascular diseaseOnce Upon a Time: The Adaptive Immune Response in Atherosclerosis--a Fairy Tale No MoreDysregulated CD4+ T cells from SLE-susceptible mice are sufficient to accelerate atherosclerosis in LDLr-/- mice.Experimental abdominal aortic aneurysm formation is mediated by IL-17 and attenuated by mesenchymal stem cell treatment.Lymphocytes and the adventitial immune response in atherosclerosis.B cell subsets in atherosclerosis.Dynamic T cell-APC interactions sustain chronic inflammation in atherosclerosisInterleukin 17 in vascular inflammation.IL-17 and TNF-α sustain neutrophil recruitment during inflammation through synergistic effects on endothelial activation.Batf3-dependent CD8α+ Dendritic Cells Aggravates Atherosclerosis via Th1 Cell Induction and Enhanced CCL5 Expression in Plaque Macrophages.Imbalanced frequencies of Th17 and Treg cells in acute coronary syndromes are mediated by IL-6-STAT3 signaling.Cortistatin reduces atherosclerosis in hyperlipidemic ApoE-deficient mice and the formation of foam cells.The altered expression of inflammation-related microRNAs with microRNA-155 expression correlates with Th17 differentiation in patients with acute coronary syndrome.Immunological Aspect of Radiation-Induced Pneumonitis, Current Treatment Strategies, and Future ProspectsBacteria present in carotid arterial plaques are found as biofilm deposits which may contribute to enhanced risk of plaque rupture.Exogenous interleukin 37 ameliorates atherosclerosis via inducing the Treg response in ApoE-deficient mice.Emerging role of IL-17 in atherosclerosis.T cells in vascular inflammatory diseasesγδT cells are prevalent in the proximal aorta and drive nascent atherosclerotic lesion progression and neutrophilia in hypercholesterolemic mice.IL-17A facilitates platelet function through the ERK2 signaling pathway in patients with acute coronary syndromeIL-17A influences essential functions of the monocyte/macrophage lineage and is involved in advanced murine and human atherosclerosis.Immune regulators of inflammation in obesity-associated type 2 diabetes and coronary artery disease.CNS-targeted production of IL-17A induces glial activation, microvascular pathology and enhances the neuroinflammatory response to systemic endotoxemia.Is serum Interleukin-17 associated with early atherosclerosis in obese patients?Increased cholesterol content in gammadelta (γδ) T lymphocytes differentially regulates their activation.Differential regulation of macropinocytosis in macrophages by cytokines: implications for foam cell formation and atherosclerosis.In vivo delivery of adenoviral vector containing interleukin-17 receptor a reduces cardiac remodeling and improves myocardial function in viral myocarditis leading to dilated cardiomyopathyInterleukin-17A gene haplotypes are associated with risk of premature coronary artery disease in Mexican patients from the Genetics of Atherosclerotic Disease (GEA) study.
P2860
Q24623195-F133105F-9DCB-4176-BA1B-BFB6B1857F4FQ26745592-F8C9A2F3-FA16-4F00-AAC1-6F0614D4374BQ26771198-28F0CA7F-84DE-40A0-9165-3458D8D98020Q26825052-A0649C06-0606-4CE3-9DC3-F775052FC286Q26853576-F15ABD35-0FAE-4606-836C-095428655F93Q26994963-EA6C5233-5429-42F0-B0BD-B052E3F182C0Q26996707-3ECD1D40-F367-4AA7-9BFC-FD00AF0165E4Q27000370-582086F9-8251-4CFD-85AD-B811FA1A7CC9Q27025697-07935945-1C7D-49A6-AC7E-F602C31CE243Q27025823-4E3AC089-5298-4775-99BC-9A51BEF68C81Q28075968-0EF31CB6-27C7-4A97-85C8-D13943F4771EQ28076613-B9C68235-8470-4E9C-AE1B-D4663169A84FQ28688590-F35FB1E5-08EF-48BA-A9B9-B180D1A93091Q30381851-A5ACE5E9-12AA-49F7-A105-64EC90A45C00Q30405805-FB5CDE3B-C79C-4B2E-AEE8-F22D29614B80Q30417206-19D08017-DB71-4559-9BDF-EF394DED90E9Q30421884-CB3AD953-1569-4EBC-AAC7-741385E59684Q30423324-06F4BF81-9676-41A8-83C0-122B011AE5F3Q30425368-107F5558-E408-41D9-ABA8-4CE0AAFF858EQ30429445-A4BAAD2D-A068-4F18-9798-5DEBF67CCDBFQ30515381-F8E4591C-0996-406F-8D61-0B9068387A03Q30847000-9F753BE0-4630-4AC3-9F5B-2D7ADF756B1DQ31133324-05C2F17A-4D30-4E6A-BBE2-3DE0DDDA25E7Q33560035-551B7120-9532-44C6-B372-5F0FACEA7E7DQ33577685-16F626A2-22E9-48A0-BA1D-B1A72D4DEA0FQ33621874-6596448A-9361-4F89-B58E-C3E3EE943059Q33751849-4D076289-3222-4DF0-8C13-536279AC2540Q33789826-6940EF2B-4F99-44B5-891C-118EDD51FD93Q33955912-D9C74667-F7B7-4524-8BB1-0A6579F4A464Q34336323-29B57A24-F8F1-4FE5-BAD8-9EA95B73348BQ34337885-BCBACD80-BB60-47DC-88EE-3B9ECD2FBC1AQ34342216-EA60EDD0-6F04-4B76-91F3-56BCE1C7036DQ34364890-21547B3B-1060-4F3A-ADBF-F158C36FAFC9Q34611614-B5F4DA8E-530E-4D0B-9DCA-0E2E1C13235EQ34611991-6E43B04E-041E-464A-B7E3-F5BD6872D4EEQ34635257-51D41366-700A-4F14-9E27-CECCD2593DCEQ34737657-F142E36E-313B-4CC0-A473-993B01732869Q34780877-3BE5FCD5-75FB-457E-B4A0-242EB2A4B4E8Q34973506-827771A8-067D-441E-8C26-5C79F860B3FCQ35007258-81F694C0-22DD-4ABB-A9CF-48DBFA487B1A
P2860
Blockade of interleukin-17A results in reduced atherosclerosis in apolipoprotein E-deficient mice.
description
2010 nî lūn-bûn
@nan
2010 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Blockade of interleukin-17A re ...... olipoprotein E-deficient mice.
@ast
Blockade of interleukin-17A re ...... olipoprotein E-deficient mice.
@en
type
label
Blockade of interleukin-17A re ...... olipoprotein E-deficient mice.
@ast
Blockade of interleukin-17A re ...... olipoprotein E-deficient mice.
@en
prefLabel
Blockade of interleukin-17A re ...... olipoprotein E-deficient mice.
@ast
Blockade of interleukin-17A re ...... olipoprotein E-deficient mice.
@en
P2093
P2860
P1433
P1476
Blockade of interleukin-17A re ...... olipoprotein E-deficient mice.
@en
P2093
Anca Dobrian
Elena Galkina
Emily Smith
Jay K Kolls
Matthew Butcher
P2860
P304
P356
10.1161/CIRCULATIONAHA.109.924886
P407
P577
2010-04-05T00:00:00Z